Lifevantage LFVN 深 沪
等待开盘 10-24 09:30:00 美东时间
5.86
-0.120
-2.01%
华盛通- 最 高5.999
- 今 开5.96
- 成交量 2.38万股
- 最 低 5.61
- 昨 收 5.98
- 总市值 7377.41万
- 52周最高 11.66
- 市盈率 静 14.68
- 换手率 0.19%
- 52周最低 3.755
- 委 比 -33.33%
- 总股本 1258.94万
- 历史最高 27.06
- 量 比 0.94
- 振 幅 6.51%
- 历史最低 0.30
- 每 手 1
- 风险率 1.14%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Lifevantage Corporation收平，成交额8.79万美元
10月20-22日上海黄浦江畔，2026可持续全球领导者大会再度来袭。诺奖、图灵奖得主现场讲述科技未来与趋势，更有“解救”焦虑、内卷时代的网红教授——麦克法兰与...
10-17 07:15
LifeVantage Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
LifeVantage Corporation granted inducement awards to its CEO, Terrence Moorehead, under its 2026 New Employee Long-Term Incentive Plan. The awards, granted on October 7, 2026, include 128,824 RSUs vesting annually over three years and 193,237 PSUs (up to 289,855 shares) based on revenue and Adjusted EBITDA margin targets over 3.5 years. LifeVantage, a pioneer in nutrigenomics, offers products that support health through science-based activators.
10-12 20:05
LifeVantage Adopts Calendar-Year Fiscal Reporting Structure
LifeVantage ( ($LFVN) ) has provided an announcement. On September 29, 2026, Li...
10-06 04:29
LifeVantage to Participate in the WTR Virtual Insights Conference on Wednesday, September 23, 2026
LifeVantage Corporation (Nasdaq: LFVN), a health and wellness company specializing in nutrigenomics, announced that CEO Terrence Moorehead and CFO Carl Aure will participate in the WTR Virtual Insights Conference on September 23, 2026. The webcast will begin at 1:30 p.m. Eastern Time and is accessible to all investors via the company’s Investor Relations website. LifeVantage, founded in 2003, offers a range of scientifically validated health prod...
09-18 12:00
美股大行评级 | 潜在涨幅768.26%！Ascendiant Capital维持RenovoRx(RNXT)"买入"评级，目标价上调至14.5美元
今日重点评级关注：Ascendiant Capital：维持RenovoRx"买入"评级，目标价从14美元升至14.5美元；HC Wainwright & Co.：维持Generate Biomedicines"买入"评级，目标价从25美元升至30美元
08-31 18:14
Lake Street Maintains Hold on Lifevantage, Raises Price Target to $6
Lake Street analyst Ryan Meyers maintains Lifevantage (NASDAQ:LFVN) with a Hold and raises the price target from $5 to $6.
08-28 23:16
Lifevantage Q4 2026 Earnings Call Transcript
On Thursday, Lifevantage (NASDAQ:LFVN) discussed fourth-quarter financial results during its earnings call. The full transcript is provided below. This transcript is brought to you by Benzinga APIs. For real-time access to our entire catalog, please visit https://www.benzinga.com/apis/ for a consult...
08-28 04:58
LifeVantage Plans To Not Issue FY27 Outlook Due To Recent CEO Transition
LifeVantage Corporation (NASDAQ:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced due to the recent transition in the Chief Executive Officer role, the Company is not issuing formal guidance for fiscal 2027...
08-28 04:16
LifeVantage (LFVN) Fiscal Q4 2026 Earnings Call: Revenue Falls 23.1%, FY2027 Guidance Withheld
LifeVantage fiscal Q4 2026 revenue fell 23.1% to $42.4 million as orders weakened. Management withheld FY2027 guidance and outlined a digital reset.
08-27 22:00
LifeVantage Declares Quarterly Dividend
LifeVantage Corporation (Nasdaq: LFVN), a leader in health and wellness products, announced that its Board of Directors has approved a quarterly cash dividend of $0.050 per share of common stock, to be paid on September 15, 2026, to stockholders of record as of September 1, 2026. The company, a pioneer in nutrigenomics, offers a range of scientifically validated products designed to support optimal health processes at the cellular level. Founded ...
08-21 12:00
